REVIEW 3 cited by
Bi-Level Graph Neural Networks for Drug-Drug Interaction Prediction
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
We introduce Bi-GNN for modeling biological link prediction tasks such as drug-drug interaction (DDI) and protein-protein interaction (PPI). Taking drug-drug interaction as an example, existing methods using machine learning either only utilize the link structure between drugs without using the graph representation of each drug molecule, or only leverage the individual drug compound structures without using graph structure for the higher-level DDI graph. The key idea of our method is to fundamentally view the data as a bi-level graph, where the highest level graph represents the interaction between biological entities (interaction graph), and each biological entity itself is further expanded to its intrinsic graph representation (representation graphs), where the graph is either flat like a drug compound or hierarchical like a protein with amino acid level graph, secondary structure, tertiary structure, etc. Our model not only allows the usage of information from both the high-level interaction graph and the low-level representation graphs, but also offers a baseline for future research opportunities to address the bi-level nature of the data.
Forward citations
Cited by 3 Pith papers
-
Zero-Shot Learning with Subsequence Reordering Pretraining for Compound-Protein Interaction
A subsequence-reordering pretraining objective with variable-length protein cuts improves zero-shot compound-protein interaction prediction and is data-efficient relative to large protein language models.
-
Graph-structured Small Molecule Drug Discovery Through Deep Learning: Progress, Challenges, and Opportunities
A structured review of graph-based deep learning for small molecule drug discovery, organized around six prediction and generation tasks.
-
Recent Developments in GNNs for Drug Discovery
A review that categorizes recent GNN-based methods for drug discovery tasks and lists benchmark datasets, without presenting new experimental results.
Discussion (0). Continue with ORCID to comment.